An2 Therapeutics, Inc. · NASDAQ:ANTX
Almitas Capital LLC reported a 5.40% stake in An2 Therapeutics, Inc. (Schedule 13G)
Event Dec 31, 2025 · Filed Feb 17, 2026
Almitas Capital LLC reported a 5.40% stake in An2 Therapeutics, Inc., 2,975,164 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G).
- Stake
- 5.40%
- Shares
- 2,975,164
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Almitas Capital LLC | 5.40% | 2,975,164 |
Source
Related
- An2 Therapeutics, Inc.
- Almitas Capital LLC
- An2 Therapeutics, Inc. shareholders
- Schedule 13G/A · Almitas Capital LLC · May 15, 2026
- Schedule 13G · Almitas Capital LLC · Nov 14, 2025
- Form 4 · Aziz Kabeer · Oct 13, 2026
- Form 4 · Martin Patricia A. · Oct 13, 2026
- Form 4 · Marks Gilbert Lynn · Oct 13, 2026
- Form 4 · Trenor Cameron C. III · Sep 16, 2026
- Form 4 · Readnour Robin Shane · Sep 11, 2026